rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

524804 AUROPHARMA Group (A)

Aurobindo Pharma Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
867.60   -18.80   -2.12%
Volume 205,105
Prev close 886.40
Day's H/L (Rs.) 896.75 - 851.00
52wk H/L (Rs.) 908.00 - 178.00
Mkt Cap (Rs. Cr) 25,290.54
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

AUROPHARMA

Aurobindo Pharma Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
871.25   -12.25   -1.39%
Volume 4,695,558
Prev close 883.50
Day's H/L (Rs.) 897.60 - 856.25
52wk H/L (Rs.) 908.00 - 178.00
Turnover (Rs. Lacs) 41,230.29
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Aurobindo Pharma Ltd.  (See all 1,959 market voices)   

140 Characters
  Cancel
Swathi - 3 hour(s) ago Dear Traders/Investers do not go with rumours trade with only SEBI Registered investment adviser with proper risk & reward ratio for more information visit http://rediff.ly/37m87 and register
#Aurobindo-Pharma-Ltd
Reply   |   Share
Swathi - 1 day(s) ago Dear Traders/Investers do not go with rumours trade with only SEBI Registered investment adviser with proper risk & reward ratio for more information visit http://rediff.ly/37m87 and register
#Aurobindo-Pharma-Ltd
Reply   |   Share

Realtime news for Aurobindo Pharma Ltd. (See all 519 news)

21 September 2014, 23:38
Stocks to watch out on Monday - 1 day(s) ago
Vanguard Group buys 23.60 lakh Aurobindo Pharma shares - 1 day(s) ago
Health care companies' scrips canter along - 6 day(s) ago
Biocon, Glenmark Pharma, Arvind to get astro support: Gupta - 10 Sep 2014
AUROBINDO PHARMA : S Q1 PROFIT SURGES TO Rs415 CRORE - 12 Aug 2014

BSE Announcements from Aurobindo Pharma Ltd. (See all)

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 - 3 day(s) ago
Aurobindo Pharma receives USFDA Approval for Amoxicillin for Oral Suspension - 5 day(s) ago

Company details for Aurobindo Pharma Ltd.

Report Card

PE Ratios
21.58
EPS (Rs.)
40.21
Sales (Rs. Cr)
1,951.00
Face Value (Rs.)
1
Net Profit
Margin (%)
 
16.31
Last Bonus
1:1
Last Dividend(%)
150
Return on
Average Equity
 
29.21

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Aurobindo Pharma Ltd. with other stocks

Apollo Hospitals Enterprise Ltd.
1,144.95
Biocon Ltd.
499.95
Show more companies
Apollo Hospitals Enterprise Ltd.
1,144.95
Biocon Ltd.
499.95
Cadila Healthcare Ltd.
1,296.75
Cipla Ltd.
620.25
Divi's Laboratories Ltd.
1,735.35
Dr. Reddy's Laboratories Ltd.
3,187.75
GlaxoSmithKline Pharmaceuticals Ltd.
2,510.75
Glenmark Pharmaceuticals Ltd.
745.05
Ipca Laboratories Ltd.
778.05
Lupin Ltd.
1,377.35
Show less companies
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close